# 바이오스페이스 일일 뉴스 리포트 - 2025년 12월 10일


## 주요 헤드라인

1. **Terns Climbs 10% As ‘Unprecedented’ Leukemia Data Beats Novartis’ Scemblix (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/terns-climbs-10-as-unprecedented-leukemia-data-beats-novartis-scemblix>

2. **Terns Climbs 10% As ‘Unprecedented’ Leukemia Data Beats Novartis’ Scemblix (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/terns-climbs-10-as-unprecedented-leukemia-data-beats-novartis-scemblix>

3. **Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-unites-with-relation-in-1-7b-inflammatory-skin-disease-pact>

4. **Structure Stock Soars as Oral GLP-1 Generates ‘Highly Competitive’ Weight Loss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/structure-stock-soars-as-oral-glp-1-generates-highly-competitive-weight-loss>

5. **Assembly’s Antivirals Show ‘Striking’ Drop in Lesions, Viral Shedding in Early Genital Herpes Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/assemblys-antivirals-show-striking-drop-in-lesions-viral-shedding-in-early-genital-herpes-study>

6. **With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/with-chinese-assets-in-hand-pharma-is-wondering-what-else-can-be-learned>

7. **With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/with-chinese-assets-in-hand-pharma-is-wondering-what-else-can-be-learned>


---
*2025년 12월 10일 바이오스페이스 뉴스 피드에서 생성된 리포트*